`PTO Form 1478 (Rev 09/2006)
`
`OMB No. 0651-0009 (Exp 02/28/2018)
`
`Trademark/Service Mark Application, Principal Register
`
`Serial Number: 86871825
`Filing Date: 01/11/2016
`
`The table below presents the data as entered.
`
`Entered
`
`86871825
`
`INTARDUO
`
`YES
`
`YES
`
`INTARDUO
`
`The mark consists of standard characters, without claim to any particular font,
`style, size, or color.
`
`Input Field
`
`SERIAL NUMBER
`
`MARK INFORMATION
`
`*MARK
`
`STANDARD CHARACTERS
`
`USPTO-GENERATED IMAGE
`
`LITERAL ELEMENT
`
`MARK STATEMENT
`
`REGISTER
`
`APPLICANT INFORMATION
`
`*OWNER OF MARK
`
`*STREET
`
`*CITY
`
`*COUNTRY
`
`*ZIP/POSTAL CODE
`(Required for U.S. applicants)
`
`LEGAL ENTITY INFORMATION
`
`TYPE
`
`STATE/COUNTRY OF INCORPORATION
`
`Principal
`
`Sanofi Biotechnology
`
`54, rue La Boétie
`
`Paris
`
`France
`
`75008
`
`corporation
`
`France
`
`GOODS AND/OR SERVICES AND BASIS INFORMATION
`
`INTERNATIONAL CLASS
`
`005(cid:160)
`
`*IDENTIFICATION
`
`FILING BASIS
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)FOREIGN REGISTRATION
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)NUMBER
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)FOREIGN REGISTRATION
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)COUNTRY
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)FOREIGN REGISTRATION
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)DATE
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)FOREIGN REGISTRATION
`
`Pharmaceutical preparations for the treatment of allergies and allergic diseases
`and disorders, autoimmune diseases and disorders, dermatological diseases
`and disorders, damaged skin and tissues, gastrointestinal diseases and
`disorders, inflammation and inflammatory diseases and disorders, respiratory
`diseases and disorders
`
`SECTION 44(e)
`
`014445852
`
`European Community
`
`11/26/2015
`
`
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)EXPIRATION DATE
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)FOREIGN REGISTRATION FILE NAME(S)
`
`08/05/2025
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)ORIGINAL PDF FILE
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)CONVERTED PDF FILE(S)
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(3 pages)
`
`reg-631381729-124059347_._INTARDUO_-
`_CTM_Reg.__F1852586x96B9E_.pdf
`
`\\TICRS\EXPORT16\IMAGEOUT16\868\718\86871825\xml1\RFA0003.JPG
`
`\\TICRS\EXPORT16\IMAGEOUT16\868\718\86871825\xml1\RFA0004.JPG
`
`\\TICRS\EXPORT16\IMAGEOUT16\868\718\86871825\xml1\RFA0005.JPG
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) STANDARD CHARACTERS
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)OR EQUIVALENT
`
`YES
`
`ADDITIONAL STATEMENTS SECTION
`
`MISCELLANEOUS STATEMENT
`
`The mark is a coined term.
`
`ATTORNEY INFORMATION
`
`NAME
`
`ATTORNEY DOCKET NUMBER
`
`FIRM NAME
`
`STREET
`
`CITY
`
`STATE
`
`COUNTRY
`
`ZIP/POSTAL CODE
`
`PHONE
`
`EMAIL ADDRESS
`
`Susan Upton Douglass
`
`SYNB 1600211
`
`Fross Zelnick Lehrman & Zissu, P.C.
`
`866 United Nations Plaza
`
`New York
`
`New York
`
`United States
`
`10017
`
`2128135900
`
`sdouglass@frosszelnick.com
`
`AUTHORIZED TO COMMUNICATE VIA EMAIL
`
`Yes
`
`DOMESTIC REPRESENTATIVE INFORMATION
`
`NAME
`
`FIRM NAME
`
`STREET
`
`CITY
`
`STATE
`
`COUNTRY
`
`ZIP CODE
`
`PHONE
`
`Susan Upton Douglass
`
`Fross Zelnick Lehrman & Zissu, P.C.
`
`866 United Nations Plaza
`
`New York
`
`New York
`
`United States
`
`10017
`
`2128135900
`
`EMAIL ADDRESS
`
`sdouglass@frosszelnick.com
`
`AUTHORIZED TO COMMUNICATE VIA EMAIL
`
`Yes
`
`CORRESPONDENCE INFORMATION
`
`NAME
`
`FIRM NAME
`
`STREET
`
`Susan Upton Douglass
`
`Fross Zelnick Lehrman & Zissu, P.C.
`
`866 United Nations Plaza
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`
`CITY
`
`STATE
`
`COUNTRY
`
`ZIP/POSTAL CODE
`
`PHONE
`
`*EMAIL ADDRESS
`
`New York
`
`New York
`
`United States
`
`10017
`
`2128135900
`
`sdouglass@frosszelnick.com
`
`*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
`
`FEE INFORMATION
`
`APPLICATION FILING OPTION
`
`TEAS RF
`
`NUMBER OF CLASSES
`
`FEE PER CLASS
`
`*TOTAL FEE DUE
`
`*TOTAL FEE PAID
`
`SIGNATURE INFORMATION
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)ORIGINAL PDF FILE
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)CONVERTED PDF FILE(S)
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(2 pages)
`
`SIGNATORY'S NAME
`
`SIGNATORY'S POSITION
`
`1
`
`275
`
`275
`
`275
`
`hw_631381729-124059347_._INTARDUO_in_Class_5_-
`_application_44_e___F1852532x96B9E_.pdf
`
`\\TICRS\EXPORT16\IMAGEOUT16\868\718\86871825\xml1\RFA0006.JPG
`
`\\TICRS\EXPORT16\IMAGEOUT16\868\718\86871825\xml1\RFA0007.JPG
`
`Edith Gourtay
`
`Legal Manager, Trademarks
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)
`
`
`Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`PTO Form 1478 (Rev 09/2006)
`
`OMB No. 0651-0009 (Exp 02/28/2018)
`
`Trademark/Service Mark Application, Principal Register
`
`Serial Number: 86871825
`Filing Date: 01/11/2016
`
`To the Commissioner for Trademarks:
`
`MARK:(cid:160)INTARDUO(cid:160)(Standard Characters, see below )
`
`The literal element of the mark consists of INTARDUO.
`The mark consists of standard characters, without claim to any particular font, style, size, or color.
`
`The applicant, Sanofi Biotechnology, a corporation of France, having an address of
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)54, rue La Boétie
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Paris 75008
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)France
`
`requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register
`established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:
`
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160) International Class 005: (cid:160)Pharmaceutical preparations for the treatment of allergies and allergic diseases and disorders, autoimmune diseases
`and disorders, dermatological diseases and disorders, damaged skin and tissues, gastrointestinal diseases and disorders, inflammation and
`inflammatory diseases and disorders, respiratory diseases and disorders
`Based on Foreign Registration: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the
`identified goods/services, and submits a copy of European Community registration number 014445852, and/or proof of renewal, registered
`11/26/2015 with a renewal date of __________ and an expiration date of 08/05/2025, and translation thereof, if appropriate.
`
`Original PDF file:
`reg-631381729-124059347_._INTARDUO_-_CTM_Reg.__F1852586x96B9E_.pdf
`Converted PDF file(s) (3 pages)
`Foreign Registration-1
`Foreign Registration-2
`Foreign Registration-3
`
`The foreign registration that is the basis of the U.S. application under §44(e) of the Trademark Act includes a claim of standard characters or the
`country of origin's standard character equivalent.
`
`Miscellaneous Statement
`The mark is a coined term.
`
`The applicant's current Attorney Information:
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Susan Upton Douglass of Fross Zelnick Lehrman & Zissu, P.C.(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)866 United Nations Plaza
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)New York, New York 10017
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)United States
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)2128135900(phone)
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)sdouglass@frosszelnick.com (authorized)
`The attorney docket/reference number is SYNB 1600211.
`
`The applicant hereby appoints Susan Upton Douglass of Fross Zelnick Lehrman & Zissu, P.C.
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)866 United Nations Plaza
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)New York New York 10017
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)United States
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)2128135900(phone)
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)sdouglass@frosszelnick.com (authorized)
`
`
`
`as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.
`
`The applicant's current Correspondence Information:
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Susan Upton Douglass
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)Fross Zelnick Lehrman & Zissu, P.C.
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)866 United Nations Plaza
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)New York, New York 10017
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)2128135900(phone)
`(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)(cid:160)sdouglass@frosszelnick.com (authorized)
`E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant or applicant's attorney
`at the e-mail address provided above. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's
`attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to
`do so will result in an additional processing fee of $50 per international class of goods/services.
`
`A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
`
`Declaration
`
`The signatory believes that: if the applicant is filing the application under 15 U.S.C. § 1051(a), the applicant is the owner of the
`trademark/service mark sought to be registered; the applicant is using the mark in commerce on or in connection with the goods/services in the
`application; the specimen(s) shows the mark as used on or in connection with the goods/services in the application; and/or if the applicant filed
`an application under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e), the applicant is entitled to use the mark in commerce; the applicant has a
`bona fide intention, and is entitled, to use the mark in commerce on or in connection with the goods/services in the application. The signatory
`believes that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the
`mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services
`of such other persons, to cause confusion or mistake, or to deceive. The signatory being warned that willful false statements and the like are
`punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the
`validity of the application or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all
`statements made on information and belief are believed to be true.
`
`Declaration Signature
`
`Signature: Not Provided (cid:160)(cid:160)(cid:160)Date: Not Provided
`Signatory's Name: Edith Gourtay
`Signatory's Position: Legal Manager, Trademarks
`RAM Sale Number: 86871825
`RAM Accounting Date: 01/12/2016
`
`Serial Number: 86871825
`Internet Transmission Date: Mon Jan 11 17:09:58 EST 2016
`TEAS Stamp: USPTO/BAS-XX.XXX.XXX.X-20160111170958749
`295-86871825-550e2f1607ee41bcacee3576468
`75d05a6377d978a25aafb9572c1b5813d5c811-D
`A-4093-20160111170814980318
`
`
`
`INTARDUO
`
`
`
`OAMI OFICINA DE ARMONIZACION DEL MERCADO INTERIOR (MARCAS, DIBUJOS Y MODELOS)
`HABM HARMONISIERUNGSAMT FUR DEN BINNENMARKT (MARKEN, MUSTER UND MODELLE)
`OHIM OFFICE FOR HARMONIZATION IN THE INTERNAL MARKET (TRADE MARKS AND DESIGNS)
`OHMI OFFICE DE L’HARMONISATION DANS LE MARCI-IE INTERIEUR (MARQUES, DESSINS ET MODELES)
`UAMI UFFICIO PER L’ARMONIZZAZ|OI\EE NEL MERCATO INTERNO (MARCHI, DISEGNI E MODELLI)
`
`. Certified Copy
`Copia Certificada . Beglaubigte Abschrift
`Copie Certifiée . Copia Autenticata
`
`Codigo de identificacion . ldentifizierungscode . Identification code .
`Code didentification . Codice di identificazione: BZX2AS626GUX5VQWW3SRE406KI
`
`Por el presente se certifica que el documento que se adjunta es una copia conforme del certificado de
`registro para la marca comunitaria cuyo numero y fecha de registro aparecen a continuacion.
`El documento original puede ser consultado en el enlace de la OAMI httg://oami.euroga.eu
`introduciendo el codigo de identificacion indicado mas arriba.
`
`Hiermit wird bestatigt, daI3 die Abschrift, die diesem Be/eg beigeheftet ist, eine genaue Abschrift der
`Eintragungsurkunde ist, die fL'ir die Gemeinschaftsmarke mit der nachstehenden Eintragungsnummer
`unci dem nacnstehenden Eintragungstag ausgestellt wurde.
`Das Originaldokument kann mitteis Eingabe eines Identifizierungscocie bei folgender Webadresse
`httg://oami.euro,ga.eu eingesehen werden.
`
`This is to certify that the attached document is an exact copy of the certificate of registration issued for
`the Community trade mark bearing the registration number and date indicated below.
`The original document can be consulted introducing the identification code indicated above at the
`following OHIM web page link httg://oami.euroga.eu.
`
`ii est certifié que le document annexe’ est une copie conforme du certificat
`Par la présente,
`denregistremenz‘ déiii/re’ pour la marque communautaire portant le numéro et la date d'enregistrement
`qui figurent cilaprés.
`Le document original peut étre consulté sur le site web de /'OH/I/II httg://oami.euroQa.eu en introduisant
`ie code didentification indfqué cf-dessus.
`
`Con la presente si certifica che il documento allegato e una copia conforme del certificato di
`registrazione per il marchio comunitario contrassegnato dal numero e dalla data di
`registrazione
`riportati sotto.
`ll Documento originale puo essere consultato introducendo ii codice di identificazione sopra indicato,
`nel indirizzo httg://oami.euroQa.eu della pagina Web della UAMI.
`
`Num./Nr./No/n°/n.
`
`Fecha/Datum/Date/Date/Data
`
`014445852
`
`26l11I2015
`
`Alicante, 11/01/2016
`
`Birgit Filtenborg
`Tel. +34 96 513 8864
`
`Departamento de Servicios al Cliente
`Hauptabteilung Kundendienstleistungen
`Customer Services Department
`Département «services aux Clients»
`Dipartimento Servizi ai Clienti
`
`Avenida de Europa, 4 - E—O3008 Alicante - Espafia. Tel. + 34—96—513_91.00 - Fax: + 34—96—513.13.44_ Internet: httg://oami.europa_eu
`
`
`
`:. . ‘O :0: Copia Certificada / Beglaubigte Abschrift/ Cenified Copy / Copie Certiflée / Copia. Autenticata
`.
`.,' W" Certificado de registro de marca comunitaria / Eintragungsurkunde der Gemeinschaftsmarke / Registration certificate of community irade markl Certiflcat
`' " '
`"M:
`(fcnrcgistrcmcnt dc marque communautairc / Ccnificato rcgistrazinnc di marchio comunitario
`
`Enregistré /' Registered 26/11/2015
`
`'
`
`No 014445852
`
`INTARDUO
`
`Le President/’ The President
`
`Antdnio Campinas
`
`Page 1 of 2
`
`cm 014445352
`
`Alienate, 11/01/2016
`
`3”;9Lb
`
`
`
`
`
`Identificat1011Code:BZXZASS2EGUXSVQWWZSRE4D6KI
`
`
`
`
`
`
`
`BZXZASGZGGUXSVQWW3SRE406KI
`
`
`
`IdentificationCode:
`
`Copia Certificada /" Beglaubigte Abschrift/' Certified Copy /' Copie Certifiee / Copia Autenticata
`Certificado de registro de rnarca cornunitaria / Eintragungsurkunde der Gemeinschaftsmarke /' Registration
`certificate of community trade mark / Certificat d'enregistrernent de marque communautaire / Certificate
`registrazione di marchio comunitario
`
`OHMI — OFFICE DE EHARMONISATION DANS LE MARCHE INTERIEUR
`MARQUEE. DESSTNS ET MODELES
`
`OHTM — OFFICE FOR HARMONIZATION IN THE INTERNAL MARKET
`TRADE MARKS AND DESIGNS
`
`I - 5
`Farmaceutlska preparat.
`
`014445852
`05/08/2015
`1 9/08/201 5
`26/11/2015
`30/11/2015
`05/08/2025
`TNTARDUO
`
`0S
`
`ANOFI BIOTECHNOLOGY
`54, rue La Boétie
`75008 Paris
`FR
`
`FR EN
`FR - 02/03/2015 - 4160958
`--5
`<17apMaL|e5'rvsuHM npenaparm.
`I.5
`Farmacéuticos (Productos -).
`I.5
`Farmaceutické pripravky.
`I.5
`Farmaceutiske praeparater.
`I.5
`Pharmazeutische Praparate.
`--5
`Farmatseutxlised preparaadid.
`I.5
`CDcxpuc:><:u1IKo’1 (!'|po'I'c'1vm -).
`I.5
`Pharmaceuticaf preparations.
`I.5
`Produxts pharmaceutiques.
`--5Prodolti farmaceutici.
`I.5
`Farmaceitiskie preparéu.
`I.5
`Farmaciniai preparafai.
`I.5
`Farmaceutskt prcizvodi‘
`I.5
`Gyégyszerészeti készftmények.
`I . 5
`Preparazzjonijiet farmat':ew1ic'i.
`I . 5
`Farmaceutische producien.
`I.5
`Farmaceutyczne (Preparaty -).
`I.5Produtos farmacéuticos.
`I.5
`Farmaceutice (Produse -).
`I . 5
`Farmaceutické pripravky.
`I . 5
`Farmacevtska preparati.
`I.5Farmaseutttset vatmtsteet.
`
`No 014445852
`
`Page 2 of 2
`
`CTM 014445852
`
`Alicante,
`
`ll/01/2016
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`APPLICATION FOR REGISTRATION OF A TRADEMARK
`
`MARK:
`
`INTARDUO
`
`CLASS:
`
`5
`
`APPLICANT:
`
`Sanofi Biotechnology
`
`ADDRESS:
`
`54, rue La Boétie
`75008 Paris
`France
`
`ENTITY:
`
`A corporation organized and existing under the laws of France
`
`OUR REF.:
`
`SYNB 160021 1
`
`The above identified applicant has a bona fide intention to use in commerce the mark
`
`shown in the above drawing for the following goods and requests that said mark be registered in
`
`the United States Patent and Trademark Office on the Principal Register established by the Act
`
`of July 5, 1946 under Section 44(e):
`
`Class 5: Pharmaceutical preparations for the treatment of allergies and allergic
`
`diseases and disorders, autoimmune diseases and disorders, dermatological
`
`diseases and disorders, damaged skin and tissues, gastrointestinal diseases and
`
`disorders, inflammation and inflammatory diseases and disorders, respiratory
`diseases and disorders
`
`European Community Registration No. 014445852 issued on November 26, 2015 and
`
`said registration is now in full force and effect. A copy of such registration is filed herewith.
`
`The mark is in standard characters and no claim is made to any particular font style, size
`
`or color.
`
`The mark is a coined term.
`
`{F185l788.1 }
`
`
`
`ADDRESS FOR CORRESPONDENCE
`
`Applicant requests that all correspondence in connection with this application be directed
`to its attorneys, the law firm ofFross Zelnick Lehrman & Zissu, P.C., 866 United Nations Plaza,
`New York, New York 10017, Attention: Susan Upton Douglass (Telephone 212-813-5 900).
`
`APPOINTMENT OF DOMESTIC REPRESENTATIVE
`
`Fross Zelnick Lehrman & Zissu, P.C., 866 United Nations Plaza, New York, New York
`
`10017 (Telephone: 212-813-5900), is hereby designated applicant’s representative upon whom
`notices or process in proceedings affecting the mark may be served.
`
`INTENTION AS OF FILING DATE
`
`If this application is signed after the application filing date, the applicant verifies that it
`had a bona fide intention to use the mark in commerce on or in connection with the goods listed
`in this application as of the application filing date.
`
`DECLARATION
`
`The undersigned being hereby warned that willful false statements and the like so made
`are punishable by fine or imprisonment, or both, under 18 U.S.C. 1001, and that such willful
`false statements and the like mayeopardize the validity of the application or any resu.lting
`registration, declares that she is properly authorized to execute this application on behalf of the
`applicant; she believes the applicant to be the owner of the trademark or service mark sought to
`be registered, or, if the application is being filed u.nder 15 U.S.C. 1051(b), she believes applicant
`to be entitled to use such mark in commerce; to the best of her knowledge and belief no other
`person, firm, corporation, or association has the right to use the above identified mark in
`commerce, either in the identical form thereof or in such near resemblance thereto as to be likely,
`when used on or in connection with the goods of such other person, to cause confusion, or to
`cause mistake, or to deceive; and all statements made of her own knowledge are tiue and all
`statements made on information and belief are believed to be true.
`
`Sanofi Biotechnology
`
`Edith Gourtay
`
`Title: Legal Manager, Trademarks
`
`Date: January 11, 2016
`
`{P18517831}

Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ ChargeStill Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.

This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.

One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site